Fig. 16.

Photo-modulated temperature increase and release of bevacizumab or Avastin^® from a hydrogel depot (1.25 mg mL⁻¹ [bevacizumab] + 2% w/w agarose) loaded with 0.01% w/w AuNPs (0.1 mg mL⁻¹ AuNPs) and a control depot without AuNPs. The hydrogel depots were exposed to blue light (508 mW cm⁻², 400–500 nm) for 10 min three times. Copyright 2016 Wiley. Reproduced from [126] with permission